Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis

Adult brainstem gliomas are difficult to classify based on radiologic and histologic features. A K27M mutation in histone 3 has been described to identify high-grade midline gliomas associated with a particularly unfavorable prognosis. While initially considered a pediatric entity, it is now known that H3K27M-mutant brainstem gliomas occur in all age groups, but they are less well understood in adults. We studied clinical, radiologic, and pathologic features of 25 brainstem gliomas diagnosed at our institution between 1994 and 2017 in subjects at least 18 years old. Seven tumors (28%) were positive for the H3K27M mutation, and their median overall survival was significantly shorter than in the H3-wildtype group (p = 0.004). Although the mutation was invariably associated with a poor prognosis, our study also illustrates the radiologic and pathologic heterogeneity in this molecular tumor subtype. The results showed that H3K27M-mutant status and clinically aggressive course cannot be ruled out based on low-grade histology on the initial biopsy, exophytic growth, only focal or minimal enhancement or an extrapontine location, such as midbrain or medulla. These results favor an integrated approach employing a combination of clinical, radiologic, histologic features as well as H3K27M immunohistochemistry for the diagnostic subclassification of adult brainstem gliomas.

[1]  J. Grill,et al.  Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma , 2015, Annals of clinical and translational neurology.

[2]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[3]  J. Delattre,et al.  Brain stem gliomas , 2001, Current opinion in neurology.

[4]  Li Ding,et al.  Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.

[5]  Y. Yoshimoto,et al.  Histone H3 K27M mutations in adult cerebellar high-grade gliomas , 2017, Brain Tumor Pathology.

[6]  C. Allis,et al.  Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation , 2014, Science.

[7]  Zhiguo Zhang,et al.  A lesson learned from the H3.3K27M mutation found in pediatric glioma , 2013, Cell cycle.

[8]  F. Ducray,et al.  Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort , 2016, Acta Neuropathologica.

[9]  M. Sanson,et al.  Molecular analysis of diffuse intrinsic brainstem gliomas in adults , 2013, Journal of Neuro-Oncology.

[10]  Sabine Mueller,et al.  The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. , 2013, Genes & development.

[11]  M. Aboian,et al.  Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation , 2017, American Journal of Neuroradiology.

[12]  J J Mazeron,et al.  Brainstem gliomas in adults: prognostic factors and classification. , 2001, Brain : a journal of neurology.

[13]  David T. W. Jones,et al.  Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. , 2013, Cancer cell.

[14]  C. James,et al.  Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma , 2014, Nature Medicine.

[15]  Kuniaki Saito,et al.  H3F3A K27M mutations in thalamic gliomas from young adult patients. , 2014, Neuro-oncology.

[16]  Nicholas J. Wang,et al.  Functionally-defined Therapeutic Targets in Diffuse Intrinsic Pontine Glioma , 2015, Nature Medicine.

[17]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[18]  C. Kramm,et al.  H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas. , 2013, American journal of clinical pathology.

[19]  J. Going.  Counting cells made easier , 2006, Histopathology.

[20]  F. Ducray,et al.  Characteristics of H3 K27M-mutant gliomas in adults , 2017, Neuro-oncology.

[21]  T. Pietsch,et al.  High frequency of H3F3AK27M mutations characterizes pediatric and adult high-grade gliomas of the spinal cord , 2015, Acta Neuropathologica.

[22]  Ranadip Pal,et al.  Erratum: Functionally defined therapeutic targets in diffuse intrinsic pontine glioma , 2015, Nature Medicine.

[23]  L. Sullivan,et al.  A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas , 2014, Acta Neuropathologica.

[24]  Michael Brudno,et al.  Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations , 2014, Nature Genetics.

[25]  E. Melhem,et al.  Tectal Gliomas: Natural History of an Indolent Lesion in Pediatric Patients , 2000, Pediatric Neurosurgery.

[26]  B. Garcia,et al.  Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma , 2013, Science.

[27]  David T. W. Jones,et al.  K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas , 2012, Acta Neuropathologica.

[28]  Hai Yan,et al.  The H3.3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults. , 2015, Human pathology.

[29]  K. Ligon,et al.  Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas , 2014, Acta Neuropathologica.

[30]  R. Lulla,et al.  Mutations in chromatin machinery and pediatric high-grade glioma , 2016, Science Advances.

[31]  D. Ellison,et al.  Molecular pathology of paediatric central nervous system tumours , 2017, The Journal of pathology.

[32]  A. Deimling,et al.  Diagnostic, prognostic and predictive relevance of molecular markers in gliomas , 2015, Neuropathology and applied neurobiology.

[33]  J. Golfinos,et al.  Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation , 2016, Acta Neuropathologica Communications.

[34]  Arie Perry,et al.  Diffuse Midline Gliomas with Histone H3‐K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations , 2016, Brain pathology.

[35]  A. Donson,et al.  H3 K27M Mutation in Gangliogliomas can be Associated with Poor Prognosis , 2017, Brain pathology.

[36]  G. Almouzni,et al.  The double face of the histone variant H3.3 , 2011, Cell Research.

[37]  T. Maruyama,et al.  Brainstem pilocytic astrocytoma with H3 K27M mutation: case report. , 2017, Journal of neurosurgery.